{
  "ptid_time": "057_S_5199_2013-08-19",
  "img_path": "/data/qiuhui/data/adni/images/057_S_5199/2013-08-19/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 36,290 mm³, 62.5% above the reference mean. With a Z-score of 1.56 (94.1th percentile), this represents moderate enlargement; hippocampal volume measures 6,923 mm³, 9.9% below the reference mean. With a Z-score of -1.11 (13.3th percentile), this represents mild atrophy; whole brain volume measures 974,542 mm³, 5.3% below the reference mean. With a Z-score of -0.66 (25.4th percentile), this represents normal volume ; entorhinal cortex volume measures 3,292 mm³, 15.4% below the reference mean. With a Z-score of -1.20 (11.6th percentile), this represents mild atrophy; fusiform gyrus volume measures 19,260 mm³, 5.8% above the reference mean. With a Z-score of 0.65 (74.2th percentile), this represents normal volume ; middle temporal gyrus volume measures 17,225 mm³, 16.1% below the reference mean. With a Z-score of -1.43 (7.7th percentile), this represents mild atrophy. ",
  "text_data": "Age is 66.8 years. Gender is Female. Education: 15 years. Handedness: Left. Race: Black or African American. Medical history: Head, Eyes, Ears, Nose and Throat; Cardiovascular; Renal-Genitourinary; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 28.0. MoCA: 22.0. Logical Memory: 11.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.64 SUVR (profound elevated); Amyloid beta: 467.10 pg/mL (mild reduced); Total tau: 155.10 pg/mL (mild reduced); Phosphorylated tau: 15.72 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows moderate ventricular enlargement and mild atrophy in the hippocampus, entorhinal cortex, and middle temporal gyrus—regions critical for memory and cognition. The MMSE is normal (28/30), but the MoCA (22/30) suggests mild cognitive impairment, supported by mildly reduced Aβ and profoundly elevated AV45 (indicating amyloid pathology).  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (MoCA and imaging support MCI, but biomarkers are mixed with normal P-tau and no APOE4 risk allele).  \n\n*Note:* The discrepancy between MMSE (normal) and MoCA (impaired) is common in early MCI, where MoCA is more sensitive to subtle deficits. The AV45 elevation strongly suggests Alzheimer’s pathology, but the lack of APOE4 and normal P-tau lowers confidence in a definitive prodromal AD diagnosis. Follow-up clinical correlation is advised.",
  "timestamp": "2025-07-26T08:15:01.591255"
}